Development of software to enable screening and severity assessment of the depression recovery process

JRCT ID: jRCT1031220528

Registered date:23/12/2022

Basic Information

• Recruitment status: Recruiting
• Health condition(s) or Problem(s) studied: As described in the inclusion criteria
• Date of first enrollment: 23/12/2022
• Target sample size: 300
• Study type: Observational

Outcome(s)

Primary Outcome

Well-being
Depressive symptoms
Quality of life
Recurrence
Remission
Recovery state

Secondary Outcome

Visualization of recurrence of mental illness
The relationship between depressive symptoms and work engagement evaluation indices, etc.

Key inclusion & exclusion criteria

• Age minimum: >= 18age old
• Age maximum: Not applicable
• Gender: Both

Include criteria

1) Patients clinically diagnosed with a depressive disorder group according to DSM-5 criteria, who have completed the acute phase of treatment and are in symptomatic remission or are undergoing maintenance treatment to prevent relapse
2) Patients who are at least 18 years of age at the time of consent
3) Patients whose attending physician determines that written consent can be obtained, or if the attending physician determines that obtaining consent from the patient is difficult, those who are able to obtain consent from a surrogate.
4) Persons who own and use a smartphone (iOS 11.0 or later or Android version 5.0 or later)

Exclude criteria

1) Patients whose condition, in the judgment of the attending physician, could be affected by the mental or physical stress caused by the measurements in this study.
2) Patients with comorbidities that may affect the measurement results of the wristband wearable device, such as paralysis of the upper limbs.
3) Other patients deemed inappropriate by the principal investigator or co-investigators.

Related Information

• Primary Sponsor: Kikuchi Toshiaki
• Source(s) of Monetary Support: Japan Science and Technology Agency,Sumitomo Pharma Co., Ltd.